Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

277
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
277
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

190
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
190
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

252
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
252
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

381
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
381
Censoring Survival Data01:09

Censoring Survival Data

218
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
218
Survival Tree01:19

Survival Tree

153
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
153

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A more interpretable regression model for count data with excess of zeros.

Statistical methods in medical research·2026
Same author

Sex differences in subjective cognition among middle-aged and older Hispanic/Latino adults: Findings from the HCHS/SOL and SOL-INCA.

The journal of prevention of Alzheimer's disease·2026
Same author

Production of gamma-polyglutamic acid with tunable molecular weight via electrofermentation using soybean protein concentrate as a feedstock.

Bioresource technology·2026
Same author

Corrigendum to "a healthy lifestyle is associated with lower risk of depression in type 2 diabetes, irrespective of genetic susceptibility: A UK biobank cohort study" [J. Affect. Disord. 405 (2026) 121657, doi:10.1016/j.jad.2026.121657].

Journal of affective disorders·2026
Same author

SERS Facemask for Rapid and Portable Sensing Mycobacterium Tuberculosis Antigens for TB Screening.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Linking GWAS risk genes to transcriptional features of major depressive disorder via in vivo Perturb-seq.

Nature genetics·2026

Related Experiment Video

Updated: Sep 5, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Feature screening for case-cohort studies with failure time outcome.

Jing Zhang1, Haibo Zhou2, Yanyan Liu3

  • 1School of Statistics and Mathematics, Zhongnan University of Economics and Law, Wuhan, China.

Scandinavian Journal of Statistics, Theory and Applications
|July 11, 2022
PubMed
Summary

This study introduces a new variable screening method for ultra-high dimensional case-cohort data, improving efficiency in large epidemiological studies. The method effectively identifies important risk factors, even when they are weakly correlated with outcomes.

Keywords:
case-cohort designmarginal hazards regression modelsure screening propertysurvival dataultrahigh-dimensional dataweighted estimating equation

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

205

Related Experiment Videos

Last Updated: Sep 5, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

205

Area of Science:

  • Biostatistics
  • Epidemiology
  • Statistical Genetics

Background:

  • Case-cohort studies offer an economical approach for large cohort studies with expensive covariate measurements.
  • Existing methods for case-cohort data are limited, especially for high-dimensional scenarios common in epidemiology.
  • Ultra-high dimensional data present unique challenges for covariate selection in epidemiological research.

Purpose of the Study:

  • To propose a novel variable screening method for ultra-high dimensional case-cohort data.
  • To address limitations in existing methods for high-dimensional epidemiological data.
  • To develop a robust procedure for identifying relevant covariates in large-scale studies.

Main Methods:

  • Developed a variable screening procedure for ultra-high dimensional case-cohort data within a proportional model framework.
  • The method allows covariate dimension to grow exponentially with sample size.
  • An iterative extension was proposed to capture jointly important but marginally weak covariates.

Main Results:

  • The proposed screening procedure demonstrates the sure screening property and ranking consistency.
  • The method is effective even when covariate dimension significantly exceeds the sample size.
  • Simulations and a real breast cancer data application validate the procedure's performance.

Conclusions:

  • The developed method provides an efficient tool for variable selection in ultra-high dimensional case-cohort studies.
  • This approach enhances the analysis of complex epidemiological data with numerous potential risk factors.
  • The findings have implications for identifying key biomarkers and risk factors in large-scale health research.